BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 17915302)

  • 1. Repeated administration of nicotine attenuates the development of morphine tolerance and dependence in mice.
    Haghparast A; Khani A; Naderi N; Alizadeh AM; Motamedi F
    Pharmacol Biochem Behav; 2008 Feb; 88(4):385-92. PubMed ID: 17915302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of naloxone and D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 and the protein kinase inhibitors H7 and H8 on acute morphine dependence and antinociceptive tolerance in mice.
    Bilsky EJ; Bernstein RN; Wang Z; Sadée W; Porreca F
    J Pharmacol Exp Ther; 1996 Apr; 277(1):484-90. PubMed ID: 8613958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nicotine attenuates naloxone-induced jumping behaviour in morphine-dependent mice.
    Zarrindast MR; Farzin D
    Eur J Pharmacol; 1996 Feb; 298(1):1-6. PubMed ID: 8867912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of morphine discontinuation phenomenon in mice by ondansetron, a selective 5-HT3 antagonist.
    Roychoudhury M; Kulkarni SK
    Methods Find Exp Clin Pharmacol; 1996 Dec; 18(10):677-83. PubMed ID: 9121224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The substance P amino-terminal metabolite substance P(1-7), administered peripherally, prevents the development of acute morphine tolerance and attenuates the expression of withdrawal in mice.
    Kreeger JS; Larson AA
    J Pharmacol Exp Ther; 1996 Nov; 279(2):662-7. PubMed ID: 8930169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition by naloxone of tolerance and dependence in mice treated acutely and chronically with morphine.
    Yano I; Takemori AE
    Res Commun Chem Pathol Pharmacol; 1977 Apr; 16(4):721-34. PubMed ID: 16322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Precipitation of abstinence-like syndrome in morphine-dependent mice by pargyline.
    Way EL; Iwamoto ET; Khanna S; Ho IK; Shen F; Loh HH
    J Pharmacol Exp Ther; 1976 Nov; 199(2):400-7. PubMed ID: 10429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicotine potentiates morphine antinociception: a possible cholinergic mechanism.
    Zarrindast MR; Nami AB; Farzin D
    Eur Neuropsychopharmacol; 1996 May; 6(2):127-33. PubMed ID: 8791038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of D1/D2 dopamine and N-methyl-D-aspartate (NMDA) receptors in morphine tolerance and dependence in mice.
    Verma A; Kulkarni SK
    Eur Neuropsychopharmacol; 1995 Jun; 5(2):81-7. PubMed ID: 7549459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antagonism by naloxone of morphine-induced single-dose dependence and antinociception in mice.
    Smits SE
    Res Commun Chem Pathol Pharmacol; 1976 Dec; 15(4):689-96. PubMed ID: 12548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockade by narcotic drugs of naloxone-precipitated jumping in morphine-dependent mice.
    Iorio LC; Deacon MA; Ryan EA
    J Pharmacol Exp Ther; 1975 Jan; 192(1):58-63. PubMed ID: 1168251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of delta 2 opioid receptors in the development of morphine dependence in mice.
    Miyamoto Y; Portoghese PS; Takemori AE
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1141-5. PubMed ID: 8383738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitation of physical dependence in mice by naloxone-precipitated jumping after a single dose of morphine.
    Smits SE
    Res Commun Chem Pathol Pharmacol; 1975 Apr; 10(4):651-61. PubMed ID: 1171511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of cholinergic and opioid receptor mechanisms in nicotine-induced antinociception.
    Zarrindast MR; Pazouki M; Nassiri-Rad S
    Pharmacol Toxicol; 1997 Nov; 81(5):209-13. PubMed ID: 9396085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The potential antinarcotic effects of guanfacine].
    Marusov IV; Bogdanov EG; Marusova IB
    Eksp Klin Farmakol; 1996; 59(3):24-7. PubMed ID: 8974578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the mechanism(s) of cholecystokinin (CCK): receptor stimulation attenuates morphine dependence in mice.
    Rezayat M; Azizi N; Zarrindast MR
    Pharmacol Toxicol; 1997 Sep; 81(3):124-9. PubMed ID: 9335069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacology of lobeline, a nicotinic receptor ligand.
    Damaj MI; Patrick GS; Creasy KR; Martin BR
    J Pharmacol Exp Ther; 1997 Jul; 282(1):410-9. PubMed ID: 9223582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antagonism of morphine-induced analgesia, tolerance and dependence by alpha-melanocyte-stimulating hormone.
    Contreras PC; Takemori AE
    J Pharmacol Exp Ther; 1984 Apr; 229(1):21-6. PubMed ID: 6323687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of indomethacin on nicotine-induced ACTH and corticosterone response.
    Bugajski J; Gadek-Michalska A; Borycz J; Głód R
    J Physiol Pharmacol; 1998 Mar; 49(1):165-73. PubMed ID: 9594419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular responses to cigarette smoke exposure in restrained conscious rats.
    Houdi AA; Dowell RT; Diana JN
    J Pharmacol Exp Ther; 1995 Nov; 275(2):646-53. PubMed ID: 7473150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.